Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
| Status: | Completed |
|---|---|
| Conditions: | Alzheimer Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 4/21/2016 |
| Start Date: | December 2008 |
| End Date: | August 2010 |
A Multi-Center Phase 1 Study of the Safety and Tolerability of Dimebon in Alzheimer's Disease Patients on Memantine (Cohort 1) and Memantine Plus Donepezil (Cohort 2)
The purpose of this study is to evaluate the safety and tolerability of dimebon given to
Alzheimer's disease patients currently on a stable dose and regimen of memantine or
memantine plus donepezil.
Alzheimer's disease patients currently on a stable dose and regimen of memantine or
memantine plus donepezil.
Inclusion Criteria:
- Alzheimer's disease
- On Memantine
- Caregiver who is willing to accompany the patient to all clinic visits
Exclusion Criteria:
- Unstable medical illnesses or significant hepatic or renal disease
- Other primary psychiatric or neurological disorders
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials